Lexicon Pharmaceuticals, Inc. (LXRX) vs Mesa Laboratories, Inc. (MLAB)
A side-by-side comparison of Lexicon Pharmaceuticals, Inc. and Mesa Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LXRX
Lexicon Pharmaceuticals, Inc.
$1.78HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT
MLAB
Mesa Laboratories, Inc.
$139.17HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT
Total return — LXRX vs MLAB
growth of $100 · dividends reinvested · last 10yLXRX -90.8% (-21.2%/yr)MLAB +27.4% (+2.4%/yr)MLAB compounded faster over this window
Log scale — wide-divergence pair
LXRX MLAB
LXRX vs MLAB: by the numbers
- •LXRX is the larger company ($788M vs $779M market cap).
- •MLAB is profitable (1.92% net margin) while LXRX runs a net loss (-147.38%).
- •LXRX grew revenue faster over the past five years (42.36% vs 12.45% CAGR).
- •MLAB pays a dividend (0.45% yield), while LXRX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | LXRX | MLAB |
|---|---|---|
| P/E ratio | N/A | 165.68 |
| PEG ratio | N/A | 12.19 |
| P/S ratio | 19.01 | 3.12 |
| P/B ratio | 4.52 | 4.13 |
| EV / EBITDA | N/A | 18.69 |
| FCF yield | N/A | 6.79% |
Profitability
| Metric | LXRX | MLAB |
|---|---|---|
| Gross margin | 98.85% | 65.99% |
| Operating margin | -98.21% | 9.00% |
| Net margin | -147.38% | 1.92% |
| ROE | -35.02% | 2.54% |
| ROIC | -23.16% | 3.29% |
Dividends
| Metric | LXRX | MLAB |
|---|---|---|
| Dividend yield | N/A | 0.45% |
| Payout ratio | N/A | 76.19% |
Growth (annualized)
| Metric | LXRX | MLAB |
|---|---|---|
| Revenue CAGR (5Y) | 42.36% | 12.45% |
| EPS CAGR (5Y) | N/A | 13.08% |
| FCF CAGR (5Y) | N/A | 4.63% |
| Total return CAGR (5Y) | -18.54% | -13.52% |
Frequently asked
- Which has grown faster, LXRX or MLAB?
- Over the past five years, LXRX grew revenue faster — LXRX at a 42.36% CAGR versus MLAB at 12.45%.
- Does LXRX or MLAB pay a bigger dividend?
- MLAB pays a dividend (0.45% yield), while LXRX has no payments in the available dividend history.
- Is LXRX or MLAB more profitable?
- MLAB runs the higher net margin — LXRX at -147.38% versus MLAB at 1.92%.
- How have LXRX and MLAB total returns compared?
- Over the past 10 years, LXRX delivered -21.03% and MLAB delivered 2.29% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Mesa Laboratories P/E ratioMesa Laboratories dividend yieldLexicon Pharmaceuticals ROEMesa Laboratories ROELexicon Pharmaceuticals operating marginMesa Laboratories operating marginLexicon Pharmaceuticals revenue growthMesa Laboratories revenue growthLexicon Pharmaceuticals free cash flowMesa Laboratories free cash flow
Lexicon Pharmaceuticals & Mesa Laboratories appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.